Melphalan (50 mg)

admin — Wed, 18 Feb 2026 10:55:12 +0000

Overview: Luprodex 22.5 mg Leuprolide Acetate Injection contains Leuprolide Acetate (22.5 mg) and is a prescription long-acting hormonal therapy used in the management of prostate cancer, endometriosis and uterine fibroids by suppressing gonadotropin release and reducing testosterone or estrogen levels. Key Benefits: – Provides sustained hormone suppression for prostate cancer and gynecological conditions – Reduces estrogen/testosterone levels to slow disease progression – Long-acting depot formulation for monthly or quarterly dosing Composition: Leuprolide Acetate (22.5 mg) How It Works: Leuprolide Acetate is a gonadotropin-releasing hormone (GnRH) agonist that initially stimulates then down-regulates GnRH receptors in the pituitary, leading to a decrease in luteinizing hormone (LH) and follicle-stimulating hormone (FSH) release, which suppresses sex hormone production. Usage Instructions: – Administer only under the supervision of a qualified healthcare professional – Usually given as a deep subcutaneous or intramuscular injection as prescribed – Follow the recommended dosing schedule strictly Side Effects: – Hot flashes, sweating, injection site discomfort – Decreased libido, mood changes – Temporary flare in symptoms at the start of therapy Precautions: – Not recommended during pregnancy or breastfeeding unless clearly advised by a physician – Monitor hormone levels and symptom response during treatment – Inform your doctor of all current medications Storage Instructions: – Store refrigerated between 2-8°C, protect from light, do not freeze Manufacturer: Cipla Ltd Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.

Hydroxyurea (500 mg)

admin — Wed, 18 Feb 2026 10:55:06 +0000

Overview: Zoladex 3.6 Injection contains Goserelin Acetate (3.6 mg), a prescription hormonal therapy used to treat prostate cancer in men by lowering testosterone levels and various hormone-sensitive conditions including breast cancer in premenopausal women, endometriosis and uterine fibroids by reducing estrogen levels. Key Benefits: – Helps slow the progression of hormone-sensitive prostate cancer – Useful in hormone therapy for select breast cancers – Aids in managing endometriosis and uterine fibroid symptoms – Administered as a monthly subcutaneous implant Composition: Goserelin Acetate (3.6 mg) How It Works: Goserelin Acetate is a GnRH (gonadotropin-releasing hormone) agonist that lowers production of sex hormones (testosterone and estrogen) by long-term pituitary receptor down-regulation, reducing hormone-driven tumor growth or gynecological symptom progression. Usage Instructions: – Administer only by a qualified healthcare professional via subcutaneous implant usually every 28 days – Follow the prescribed schedule strictly for effective hormone suppression – Not for self-administration Side Effects: – Hot flashes, sweating, headache – Reduced libido or sexual dysfunction – Mood changes, injection site discomfort – Bone mineral density reduction with long-term use Precautions: – Not to be used during pregnancy or breastfeeding — discuss with your healthcare provider – Regular monitoring of hormone levels, bone health and symptoms is advised – Inform your doctor of all current medications before starting treatment Storage Instructions: – Store below 25°C in a cool, dry place away from moisture and light Manufacturer: AstraZeneca / Generic Pharmaceuticals Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.

prostate cancer hormone therapy – Globalstar International

Melphalan (50 mg)

Hydroxyurea (500 mg)